Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
16,517 results
- Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.: Complete Statistical AnalysisIndependent statistical analysis of Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KetPTSDIndependent statistical analysis of Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00749203).
- KEYNOTE-782Independent statistical analysis of Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Kharitode TBIndependent statistical analysis of Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02808507).
- KHLADIndependent statistical analysis of Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00953576).
- KIIndependent statistical analysis of Electromyostimulation and Strength Walking for Knee Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02065518).
- KIC-STARTIndependent statistical analysis of Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Kick Out Parkinson’s Disease 2: Complete Statistical AnalysisIndependent statistical analysis of Kick Out Parkinson's Disease 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03882879).
- Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS: Complete Statistical AnalysisIndependent statistical analysis of Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- KIDPROAMIndependent statistical analysis of Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- KINDREDIndependent statistical analysis of Ketamine for Relapse Prevention in Recurrent Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02661061).
- Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System – Phase 2: Complete Statistical AnalysisIndependent statistical analysis of Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System - Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Kinematic-guided BoNT-A Treatment for ET and PD Tremor: Complete Statistical AnalysisIndependent statistical analysis of Kinematic-guided BoNT-A Treatment for ET and PD Tremor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02427646).
- KINETICIndependent statistical analysis of Ketamine to Improve Recovery After Cesarean Delivery - Part 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04037085).
- Kinetic Anesthesia Device Study: Complete Statistical AnalysisIndependent statistical analysis of Kinetic Anesthesia Device Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03344510).
- KINGIndependent statistical analysis of Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- KINGFISHERIndependent statistical analysis of Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- kINSHIPIndependent statistical analysis of HIV Prevention Peer Navigation for Justice Involved Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04680390).
- KIRMONOIndependent statistical analysis of Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- KIS-IVIndependent statistical analysis of Advancing Tobacco Use Treatment for African American Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02360631).
- KISSIndependent statistical analysis of Aripiprazole, Abilify Maintena Collaborative Clinical Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02472652).
- KIU!Independent statistical analysis of Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men: primary endpoint results, effect estimate with confidence interval,…
- KIWIIndependent statistical analysis of Effect of Kiwifruit on Gastrointestinal Fluid Distribution and Transit in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KL4-AHRF-01Independent statistical analysis of Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- KNOCOUT PEIndependent statistical analysis of An International Pulmonary Embolism Registry Using EKOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03426124).
- Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne: Complete Statistical AnalysisIndependent statistical analysis of Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Kokkerelli Learning Street Effect Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Kokkerelli Learning Street Effect Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04190680).
- KOMETIndependent statistical analysis of Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- KontRASt-06Independent statistical analysis of Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1…
- KP415 Classroom Study in Children (6-12 Years of Age) With ADHD: Complete Statistical AnalysisIndependent statistical analysis of KP415 Classroom Study in Children (6-12 Years of Age) With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- KPL-301 for Subjects With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of KPL-301 for Subjects With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03827018).
- KReDOIndependent statistical analysis of KAP for Depression in Abstinent Opioid Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05193318).
- ktpumpIndependent statistical analysis of Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00574405).
- KUPAIndependent statistical analysis of Implementation of Knowledge-Based Palliative Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02708498).
- KurboIndependent statistical analysis of A Study to Assess the Compliance and Impact on Weight of Kurbo, a Pediatric Centered Weight Loss App: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- L-arginine in Treatment as Usual in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of L-arginine in Treatment as Usual in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00718510).
- L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: Complete Statistical AnalysisIndependent statistical analysis of L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733407).
- L-ThyroxineIndependent statistical analysis of Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06660823).
- La ComunidadIndependent statistical analysis of Latinos Combating Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831921).
- LA-CEAL 4.0: Wearable Sensor Project: Complete Statistical AnalysisIndependent statistical analysis of LA-CEAL 4.0: Wearable Sensor Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06086028).
- Lab Evaluation of Novel Hearing Aid Coupling Method: Complete Statistical AnalysisIndependent statistical analysis of Lab Evaluation of Novel Hearing Aid Coupling Method: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05377359).
- Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114971).
- Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: Complete Statistical AnalysisIndependent statistical analysis of Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01844687).
- Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LABYRIndependent statistical analysis of Wayfinding Intervention in High-Fidelity Long-Term Memory: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04253587).
- LACLOTIndependent statistical analysis of Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LADIIIndependent statistical analysis of Labor and Delivery Implant Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02866643).
- LAG-3/IMP321Independent statistical analysis of Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01308294).
- LAGB as a Treatment for Morbid Obesity in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of LAGB as a Treatment for Morbid Obesity in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01045499).